American Needle, Inc. v. NFL
Citation: 560 U.S. 183 (Supreme Court, 2010)
Facts
The NFL’s 32 teams collectively formed a licensing entity (NFL Properties) to license their intellectual property — team names, logos, and trademarks — to manufacturers on an exclusive basis. American Needle had previously held a non-exclusive license to make NFL-branded headwear but lost it when the NFL granted an exclusive license to Reebok. American Needle sued under Sherman Act § 1, alleging a conspiracy in restraint of trade. The NFL argued it was a single entity incapable of conspiring with itself.
Issue
Whether the NFL and its 32 member teams constitute a single entity for purposes of Sherman Act § 1 such that their joint licensing decisions are immune from § 1 scrutiny.
Holding
No. The Supreme Court held unanimously that the NFL teams are separate economic actors with separate economic interests and that their collective licensing decisions constitute concerted action subject to § 1 analysis. The case was remanded for rule of reason analysis.
Rule
The single-entity defense under § 1 turns on whether the alleged conspirators have a “unity of interest” — whether they are truly a single enterprise pursuing a single set of economic interests. Separate entities with separate economic stakes in competition with one another are capable of conspiring even when they cooperate through a common entity. The NFL teams compete against each other for fans, players, coaches, and merchandise revenue, and thus retain separate interests.
Significance
American Needle is the key case for the single-entity defense in antitrust law and is essential reading alongside Copperweld Corp. v. Independence Tube Corp. (holding that a parent and wholly owned subsidiary are a single entity). The case sets the test for when a joint venture or trade association is so integrated that it acts as one entity versus when it remains a collection of independent actors. It is also significant for understanding how sports leagues straddle the line — requiring horizontal cooperation to function while remaining subject to antitrust scrutiny.